AUTOMATED GMP-COMPATIBLE CRISPR-CAS9 EDITING OF HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCS) FOR THE TREATMENT OF β-HEMOGLOBINOPATHIES

被引：0
|
作者：
Urena-Bailen, G. [1 ,2 ]
Block, M.
机构：
[1] Miltenyi Biotec BV & Co KG, Bergisch Gladbach, Nordrhein Westf, Germany
[2] Univ Klinikum Tubingen, Oncol & Hematol, Tubingen, Baden Wurttembe, Germany
来源：
CYTOTHERAPY | 2023年 / 25卷 / 06期
关键词：
beta-hemoglobnopathies; GMP-compatible; CRISPR-Cas9;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
402
引用
收藏
页码：S124 / S124
页数：1
相关论文
共 50 条
  • [41] CRISPR-Cas9 Genome Editing of Primary Chronic Lymphocytic Leukemia Cells
    Mateos-Jaimez, Judith
    Mangolini, Maurizio
    Vidal, Anna
    Colomer, Dolors
    Campo, Elias
    Ringshausen, Ingo
    Martin-Subero, Jose, I
    Maiques-Diaz, Alba
    BLOOD, 2022, 140 : 9849 - 9850
  • [42] Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited HSPCs
    Crippa, S.
    Conti, A.
    Vavassori, V.
    Rivis, S.
    Bosotti, R.
    Beretta, S.
    Ferrari, S.
    Scala, S.
    Pirroni, S.
    Jofra-Hernandez, R.
    Santi, L.
    Basso-Ricci, L.
    Merelli, I.
    Genovese, P.
    Aiuti, A.
    Naldini, L.
    Di Micco, R.
    Bernardo, M. E.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A57 - A57
  • [43] CRISPR-Cas9: A Potent Gene-editing Tool for the Treatment of Cancer
    Mishra, Gauri
    Srivastava, Kamakshi
    Rais, Juhi
    Dixit, Manish
    Singh, Vandana Kumari
    Mishra, Lokesh Chandra
    CURRENT MOLECULAR MEDICINE, 2024, 24 (02) : 191 - 204
  • [44] Nanomedicine enables efficient CRISPR-Cas9 genome editing for disease treatment
    Ma, Lifang
    Dong, Caihong
    Yu, Meihua
    Song, Xinran
    Yu, Yongchun
    Chen, Yu
    SCIENCE BULLETIN, 2022, 67 (06) : 572 - 576
  • [45] Expanding CRISPR Genome Editing Strategies in Hematopoietic Stem and Progenitor Cells for the Treatment of Hematologic Diseases
    deDreuzy, Edouard
    Chalishazar, Aditi
    Heath, Jack
    Margulies, Carrie M.
    Labella, John
    Viswanathan, Ramya
    Loveluck, Katherine
    Chang, KaiHsin
    Jayaram, Hariharan
    Zuris, John A.
    Myer, Vic E.
    Albright, Charlie
    Cotta-Ramusino, Cecilia
    Gori, Jennifer L.
    BLOOD, 2017, 130
  • [46] Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells
    Pavani, Giulia
    Fabiano, Anna
    Laurent, Marine
    Amor, Fatima
    Cantelli, Erika
    Chalumeau, Anne
    Maule, Giulia
    Tachtsidi, Alexandra
    Concordet, Jean-Paul
    Cereseto, Anna
    Mavilio, Fulvio
    Ferrari, Giuliana
    Miccio, Annarita
    Amendola, Mario
    BLOOD ADVANCES, 2021, 5 (05) : 1137 - 1153
  • [47] Precise detection of CRISPR-Cas9 editing in hair cells in the treatment of autosomal dominant hearing loss
    Cui, Chong
    Wang, Daqi
    Huang, Bowei
    Wang, Fang
    Chen, Yuxin
    Lv, Jun
    Zhang, Luping
    Han, Lei
    Liu, Dong
    Chen, Zheng-Yi
    Li, Geng-Lin
    Li, Huawei
    Shu, Yilai
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 29 : 400 - 412
  • [48] Precise detection of CRISPR-Cas9 editing in hair cells in the treatment of autosomal dominant hearing loss
    Cui, Chong
    Wang, Daqi
    Huang, Bowei
    Wang, Fang
    Chen, Yuxin
    Lv, Jun
    Zhang, Luping
    Han, Lei
    Liu, Dong
    Chen, Zheng-Yi
    Li, Geng-Lin
    Li, Huawei
    Shu, Yilai
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 29 : 400 - 412
  • [49] Focused-ultrasound-mediated CRISPR-Cas9 gene editing in human induced pluripotent stem cells
    Owusu-Yaw, Bernie Simone
    MOLECULAR THERAPY, 2025, 33 (03) : 831 - 832
  • [50] Highly efficient genome editing via CRISPR-Cas9 ribonucleoprotein (RNP) delivery in mesenchymal stem cells
    Han, A. Reum
    Shin, Ha Rim
    Kweon, Jiyeon
    Lee, Soo Been
    Lee, Sang Eun
    Kim, Eun-Young
    Kweon, Jiyeon
    Chang, Eun-Ju
    Kim, Yongsub
    Kim, Seong Who
    BMB REPORTS, 2024, 57 (01) : 60 - 65
12345